Skip to main content

Domainex

  • About
    • Case Studies
    • Testimonials
    • Board members
    • Investors
    • Management team
    • Contact us
  • Services
    • Offerings
      • Protein Science
      • X-ray crystallography
      • Assay Development
      • Biophysics
      • Biochemistry
      • Synthetic Chemistry
      • Virtual screening
      • Screening
      • Computational Chemistry
      • Medicinal Chemistry
      • Cell Biology
      • ADME and Bioanalytical Sciences
      • Analytical Sciences
      • Grating-Coupled Interferometry
    • Research Phases
      • Hit Identification
      • Hit to Lead
      • Lead Optimisation
    • Therapeutic Areas
      • Oncology
      • Immuno-Oncology
      • Cardiovascular
      • Respiratory
      • Anti-infectives
      • Inflammatory diseases
    • Target Classes
      • Kinases
      • GPCRs
      • Proteases
      • Methyltransferases
      • Ion Channels
      • Protein-Protein Interactions
    • Approaches
      • CDH (Target Gene Fragmentation)
      • PoLiPa (Membrane Protein Solubilisation)
      • LeadBuilder
      • FragmentBuilder
      • Fragment Based Drug Discovery (FBDD)
      • Structure Based Drug Design (SBDD)
  • Library
    • Articles
    • Brochures
    • Posters
    • Presentations
    • Publications
    • White Papers
  • News & Events
  • Careers
Enquire

News & Events

Breadcrumb

  1. Home
  2. News & Events

News

Will the rise of biologics be the death of traditional medicinal chemistry?

18 Feb '21
Blog Post

Driving scientific advancement with diversity

11 Feb '21
Blog Post

Domainex expands executive team to support ongoing growth

21 Jan '21
Press Release

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

12 Jan '21
Press Release

Domainex recognised as leading CRO

6 Jan '21
Blog Post

Outsourcing for rapid COVID-19 drug development

16 Dec '20
Blog Post
View more

Events

Apr 14 Kinase 2021

Apr 29 32nd symposium on Medicinal Chemistry in Eastern England

Jun 11 OBN Awards

Jun 17 BioForward

Aug 28 XXVI EFMC International Symposium on Medicinal Chemistry

View more

Tweets

Tweets by Domainex_UK

Start your next project with Domainex

Contact one of our experts today
Domainex
  • About
    • Case Studies
    • Testimonials
    • Board members
    • Investors
    • Management team
    • Contact us
  • Services
    • Offerings
      • Protein Science
      • X-ray crystallography
      • Assay Development
      • Biophysics
      • Biochemistry
      • Synthetic Chemistry
      • Virtual screening
      • Screening
      • Computational Chemistry
      • Medicinal Chemistry
      • Cell Biology
      • ADME and Bioanalytical Sciences
      • Analytical Sciences
      • Grating-Coupled Interferometry
    • Research Phases
      • Hit Identification
      • Hit to Lead
      • Lead Optimisation
    • Therapeutic Areas
      • Oncology
      • Immuno-Oncology
      • Cardiovascular
      • Respiratory
      • Anti-infectives
      • Inflammatory diseases
    • Target Classes
      • Kinases
      • GPCRs
      • Proteases
      • Methyltransferases
      • Ion Channels
      • Protein-Protein Interactions
    • Approaches
      • CDH (Target Gene Fragmentation)
      • PoLiPa (Membrane Protein Solubilisation)
      • LeadBuilder
      • FragmentBuilder
      • Fragment Based Drug Discovery (FBDD)
      • Structure Based Drug Design (SBDD)
  • Library
    • Articles
    • Brochures
    • Posters
    • Presentations
    • Publications
    • White Papers
  • News & Events
  • Careers
COVID-19

+44 (0) 1223 743170 enquiries@domainex.co.uk

Offerings

  • Protein Science
  • X-Ray crystallography
  • Assay Development
  • Biophysics
  • Biochemistry
  • Synthetic Chemistry
  • Screening
  • Computational Chemistry
  • Medicinal Chemistry
  • Cell Biology
  • ADME and Bioanalytical Sciences
  • Analytical Sciences
  • Ligand binding assays by Surface Plasmon Resonance (SPR) and/or Grating-Coupled Interferometry (GCI)

Research Phases

  • Hit Identification
  • Hit to Lead
  • Lead Optimisation

Therapeutic Areas

  • Oncology
  • Immuno-Oncology
  • Cardiovascular
  • Respiratory Disease
  • Anti-infectives
  • Inflammatory diseases

Target Classes

  • Kinases
  • GPCRs
  • Proteases
  • Protein Methyltransferases
  • Ion Channels
  • Protein-Protein Interactions

Approaches

  • CDH (Target Gene Fragmentation)
  • Innovative Polymer Lipid Particle (PoLiPa) Technology
  • LeadBuilder – Virtual Screening
  • FragmentBuilder
  • Structure Based Drug Design (SBDD)

Domainex is a registered company (number 4336899)

Site and its contents Copyright © Domainex 2021. All rights reserved.